Cases & Deals

Sterling Biotech restructures $134.5 million of its outstanding Zero Coupon Convertible Bonds

Clients Sterling Biotech Limited

Jones Day advised Sterling Biotech Limited, a manufacturer of pharmaceutical products, on the restructuring of $134.5 million of its outstanding Zero Coupon Convertible Bonds due 2012, including the underlying redemption premium, in a cashless exchange offer for $205 million of Zero Coupon Compulsorily Convertible Bonds due 2019.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.